Zhuhai Livzon Group net profit is still the main industry to enhance

 Zhongguang Wang Zhuhai May 15 news yesterday morning, sponsored by the GF Securities, The problem of when to resume trading, Franc strictly follow the disclosure system, simply responded, 60%. Some investors asked the reason, as was Deputy General Manager Lee said that the secondary market in the stock market dragged down the total profits of Cabernet Franc, but in fact, in the first quarter Lizhu Group revenue and net profit are the main business improvement there has been no deviation from relying mainly on investment earnings on the main business of the phenomenon. Livzon Group 2007 annual report, the end of last year, its total investment in the Chenming Paper, Shenzhen International, Country Garden, etc., of the 10 listed companies, and hold Bank of Communications, South pharmaceuticals, medicine and other three listed companies in East China's equity. by the great bull market of the favorable factors, Livzon trading financial assets last year reached 448 million, than the beginning of the year up 2.79 billion yuan, the rate of increase of 166.19%, which are caused by the securities investment. This year the stock market turmoil makes Franc stocks making big money no longer, therefore, investment in securities with investors concerned about the direction of Cabernet Franc. Li as it responded that the direction of investment Franc the top two companies in the industry. The new plant construction without additional requirements under the relevant planning, Franc Western pharmaceutical will be relocated. Investors are concerned about the new plant's size and funding sources, in particular, will therefore additional Franc needs. Lee as it said in the Harbor Industrial Zone Franc plans a 420,000 square meters of land construction of new plants, one at least 4 billion yuan of funds, but the exact funding requirements will be clear only after the project started. The new plant scale 4 times more than the current largest, will build the world's most advanced pharmaceutical production base. funds, bank loans increase its own funds Franc fully meet the needs of a building. new drugs have little effect on performance before the short term, Lizhu Group is pushing a new class of drugs approved, heavy products. Pula yl for more cooperation in the field. However, these past 2 to 3 years on the company's operating performance has little effect. a good assessment of earthquake loss temporarily Franc Everbright Group, a wholly owned subsidiary of Sichuan Pharmaceutical Co., Ltd. affected by the earthquake happened in the Chengdu, more serious disasters, earthquakes therefore investors expressed concern about the impact on the Franc. Lee said as before, due to the impact of power failures and other reasons, the group has been discontinued pharmacy, there are some plants collapsed and cracks appeared the phenomenon, as there is still In the emergency phase, the company lost a bad evaluation. Once the earthquake have a significant impact on operating results, Franc-related announcements will be logged out, timely disclosure.